To further determine the clinicopathologic significance of cyclin B1, Sec62, and Birc3 in HCC, immunohistochemical analysis was performed from 35 recurrent tissues and 45 non-recurrent ones. This evidence concerns the gene BIRC3 and hepatocellular carcinoma.